Prevalenza e controllo dell'ipertensione arteriosa nei pazienti in trattamento emodialitico cronico

risultati di un audit clinico monocentrico.

Translated title of the contribution: [Prevalence and control of hypertension in chronic hemodialysis patients: results of a single-centre clinical audit].

Antonio Del Giudice, Antonio Cicchella, Giuseppe Di Giorgio, Matteo Piemontese, Michele Prencipe, Andrea Fontana, Massimiliano Copetti, Fabio Pellegrini, Filippo Aucella

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hypertension (HTN) is very common in chronic hemodialysis patients, with a prevalence of 72%, a very poor control and an annual mortality of 23%. We report the results of a clinical audit on prevalence and control of HTN in our hemodialysis patients. The following parameters in a cohort of 89 patients were assessed in one-month observational study, conducted in October 2010: blood pressure (BP) before the beginning (preHD BP) and after the end of the treatment (postHD BP), age, sex, comorbidity, serum hemoglobin (Hb) levels, plasma and dialysate sodium levels, interdialytic weight gain (IWG), serum parathyroid hormone (PTH) levels, prescription of erythropoiesis stimulating agents (ESA) and of antihypertensive drugs. In agreeement to the current guidelines, patients with preHD BP ≤140/90 mmHg and postHD BP ≤130/80 mmHg were considered normortensive. Forty-nine patients (55%) were found to be hypertensive. The following comorbidities, graded as 1+ to 3+, were detected: ischemic/hypertrophic cardiopathy, dyslipidemia, peripheral arteriopathy, diabetes mellitus. Only 14.3% of patients achieved both preHD and postHD BP targets. Compared to patients whose BP was not controlled, those achieving BP targets were younger, had lower dialysate sodium levels and showed a greater IWG. No significant difference there was in serum Hb levels, plasma sodium levels, serum PTH levels, prescription of antihypertensive drugs and ESA. Our data confirm the high prevalence of HTN and the unsatisfactory BP control in hemodialysis patients. A low-salt diet, probing for dry-weight and the antihypertensive medication may help to achieve the BP control.

Original languageItalian
Pages (from-to)230-237
Number of pages8
JournalGiornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia
Volume29
Issue number2
Publication statusPublished - Mar 2012

Fingerprint

Clinical Audit
Renal Dialysis
Blood Pressure
Hypertension
Hematinics
Antihypertensive Agents
Sodium
Dialysis Solutions
Parathyroid Hormone
Serum
Weight Gain
Comorbidity
Hemoglobins
Sodium-Restricted Diet
Prescription Drugs
Dyslipidemias
Observational Studies
Prescriptions
Diabetes Mellitus
Guidelines

ASJC Scopus subject areas

  • Nephrology

Cite this

Prevalenza e controllo dell'ipertensione arteriosa nei pazienti in trattamento emodialitico cronico : risultati di un audit clinico monocentrico. / Del Giudice, Antonio; Cicchella, Antonio; Di Giorgio, Giuseppe; Piemontese, Matteo; Prencipe, Michele; Fontana, Andrea; Copetti, Massimiliano; Pellegrini, Fabio; Aucella, Filippo.

In: Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia, Vol. 29, No. 2, 03.2012, p. 230-237.

Research output: Contribution to journalArticle

Del Giudice, Antonio ; Cicchella, Antonio ; Di Giorgio, Giuseppe ; Piemontese, Matteo ; Prencipe, Michele ; Fontana, Andrea ; Copetti, Massimiliano ; Pellegrini, Fabio ; Aucella, Filippo. / Prevalenza e controllo dell'ipertensione arteriosa nei pazienti in trattamento emodialitico cronico : risultati di un audit clinico monocentrico. In: Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia. 2012 ; Vol. 29, No. 2. pp. 230-237.
@article{3d84e6050aab4e62a0da622dcb770282,
title = "Prevalenza e controllo dell'ipertensione arteriosa nei pazienti in trattamento emodialitico cronico: risultati di un audit clinico monocentrico.",
abstract = "Hypertension (HTN) is very common in chronic hemodialysis patients, with a prevalence of 72{\%}, a very poor control and an annual mortality of 23{\%}. We report the results of a clinical audit on prevalence and control of HTN in our hemodialysis patients. The following parameters in a cohort of 89 patients were assessed in one-month observational study, conducted in October 2010: blood pressure (BP) before the beginning (preHD BP) and after the end of the treatment (postHD BP), age, sex, comorbidity, serum hemoglobin (Hb) levels, plasma and dialysate sodium levels, interdialytic weight gain (IWG), serum parathyroid hormone (PTH) levels, prescription of erythropoiesis stimulating agents (ESA) and of antihypertensive drugs. In agreeement to the current guidelines, patients with preHD BP ≤140/90 mmHg and postHD BP ≤130/80 mmHg were considered normortensive. Forty-nine patients (55{\%}) were found to be hypertensive. The following comorbidities, graded as 1+ to 3+, were detected: ischemic/hypertrophic cardiopathy, dyslipidemia, peripheral arteriopathy, diabetes mellitus. Only 14.3{\%} of patients achieved both preHD and postHD BP targets. Compared to patients whose BP was not controlled, those achieving BP targets were younger, had lower dialysate sodium levels and showed a greater IWG. No significant difference there was in serum Hb levels, plasma sodium levels, serum PTH levels, prescription of antihypertensive drugs and ESA. Our data confirm the high prevalence of HTN and the unsatisfactory BP control in hemodialysis patients. A low-salt diet, probing for dry-weight and the antihypertensive medication may help to achieve the BP control.",
author = "{Del Giudice}, Antonio and Antonio Cicchella and {Di Giorgio}, Giuseppe and Matteo Piemontese and Michele Prencipe and Andrea Fontana and Massimiliano Copetti and Fabio Pellegrini and Filippo Aucella",
year = "2012",
month = "3",
language = "Italian",
volume = "29",
pages = "230--237",
journal = "Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia",
issn = "0393-5590",
publisher = "Wichtig Publishing Srl",
number = "2",

}

TY - JOUR

T1 - Prevalenza e controllo dell'ipertensione arteriosa nei pazienti in trattamento emodialitico cronico

T2 - risultati di un audit clinico monocentrico.

AU - Del Giudice, Antonio

AU - Cicchella, Antonio

AU - Di Giorgio, Giuseppe

AU - Piemontese, Matteo

AU - Prencipe, Michele

AU - Fontana, Andrea

AU - Copetti, Massimiliano

AU - Pellegrini, Fabio

AU - Aucella, Filippo

PY - 2012/3

Y1 - 2012/3

N2 - Hypertension (HTN) is very common in chronic hemodialysis patients, with a prevalence of 72%, a very poor control and an annual mortality of 23%. We report the results of a clinical audit on prevalence and control of HTN in our hemodialysis patients. The following parameters in a cohort of 89 patients were assessed in one-month observational study, conducted in October 2010: blood pressure (BP) before the beginning (preHD BP) and after the end of the treatment (postHD BP), age, sex, comorbidity, serum hemoglobin (Hb) levels, plasma and dialysate sodium levels, interdialytic weight gain (IWG), serum parathyroid hormone (PTH) levels, prescription of erythropoiesis stimulating agents (ESA) and of antihypertensive drugs. In agreeement to the current guidelines, patients with preHD BP ≤140/90 mmHg and postHD BP ≤130/80 mmHg were considered normortensive. Forty-nine patients (55%) were found to be hypertensive. The following comorbidities, graded as 1+ to 3+, were detected: ischemic/hypertrophic cardiopathy, dyslipidemia, peripheral arteriopathy, diabetes mellitus. Only 14.3% of patients achieved both preHD and postHD BP targets. Compared to patients whose BP was not controlled, those achieving BP targets were younger, had lower dialysate sodium levels and showed a greater IWG. No significant difference there was in serum Hb levels, plasma sodium levels, serum PTH levels, prescription of antihypertensive drugs and ESA. Our data confirm the high prevalence of HTN and the unsatisfactory BP control in hemodialysis patients. A low-salt diet, probing for dry-weight and the antihypertensive medication may help to achieve the BP control.

AB - Hypertension (HTN) is very common in chronic hemodialysis patients, with a prevalence of 72%, a very poor control and an annual mortality of 23%. We report the results of a clinical audit on prevalence and control of HTN in our hemodialysis patients. The following parameters in a cohort of 89 patients were assessed in one-month observational study, conducted in October 2010: blood pressure (BP) before the beginning (preHD BP) and after the end of the treatment (postHD BP), age, sex, comorbidity, serum hemoglobin (Hb) levels, plasma and dialysate sodium levels, interdialytic weight gain (IWG), serum parathyroid hormone (PTH) levels, prescription of erythropoiesis stimulating agents (ESA) and of antihypertensive drugs. In agreeement to the current guidelines, patients with preHD BP ≤140/90 mmHg and postHD BP ≤130/80 mmHg were considered normortensive. Forty-nine patients (55%) were found to be hypertensive. The following comorbidities, graded as 1+ to 3+, were detected: ischemic/hypertrophic cardiopathy, dyslipidemia, peripheral arteriopathy, diabetes mellitus. Only 14.3% of patients achieved both preHD and postHD BP targets. Compared to patients whose BP was not controlled, those achieving BP targets were younger, had lower dialysate sodium levels and showed a greater IWG. No significant difference there was in serum Hb levels, plasma sodium levels, serum PTH levels, prescription of antihypertensive drugs and ESA. Our data confirm the high prevalence of HTN and the unsatisfactory BP control in hemodialysis patients. A low-salt diet, probing for dry-weight and the antihypertensive medication may help to achieve the BP control.

UR - http://www.scopus.com/inward/record.url?scp=84880811928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880811928&partnerID=8YFLogxK

M3 - Articolo

VL - 29

SP - 230

EP - 237

JO - Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia

JF - Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia

SN - 0393-5590

IS - 2

ER -